Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Eye Care International Acquires N-CAM.


TAMPA, Fla. -- Eye Care International, Inc. (EYCI EYCI Eye Care International Inc (stock symbol) ) announced today that it has completed its acquisition of N-CAM N-CAM Neural Cell-Adhesion Molecule (R), the nation's first and leading Complementary and Alternative Medicine The term complementary and alternative medicine (CAM) is an umbrella term for alternative medicine and complementary medicine.

Alternative medicine describes practices used in place of conventional medical treatments.
 organization. This completes Eye Care International's acquisition plans for 2004, and integration and cross selling between the two companies is scheduled for immediate launch in January 2005.

"We are particularly pleased to have also retained the services of N-CAM(R)'s founder, Elizabeth Gannon, who has over twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights.
     2.
 of experience in the health care delivery arena. She brings with her not only a wealth of experience but tremendous cross-selling opportunities between the two companies," said Clark A. Marcus, Eye Care International's Chief Executive Officer. "With the acquisition of N-CAM(R), Eye Care International is now not only the nation's largest discount vision plan, but also the largest provider of wellness programs in the nation," added Marcus.

Elizabeth Gannon, N-CAM(R) CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  said, "Eye Care International's Vision Plan was selected for distribution to N-CAM(R) members earlier year. Having access to free eye exams through qualified eye care professionals made the Eye Care International Vision Plan the obvious plan for adoption. In addition, Eye Care International's Photoscreener(TM) technology will enhance N-CAM(R) wellness offerings to children and adults via early detection and treatment of eye irregularities."

N-CAM(R) is the leader in Complementary and Alternative Medicine consumer and discounted health plan solutions. N-CAM(R) has been the driving force behind the move of many major distributors of discount health related services nationally. Introducing new and improved ways to empower individuals, health plan members and employees to improve their ability to expand their options for healthy living, provide knowledge and qualified information and access to high quality health products and services though the Company's new eHealthPlan Solutions.

Eye Care International, Inc. owns and operates the nation's largest discount vision network, with provider locations nationwide. It is the only discount vision plan providing the services of ophthalmologists (MDs) who discount all their services including cosmetic surgical procedures such as LASIK LASIK laser-assisted in-situ keratomileusis.

LA·SIK
n.
Eye surgery in which the surface of the cornea is reshaped using a laser, performed to correct certain refractive disorders such as myopia.
 vision correction and Co2 Laser Skin Resurfacing. Eye Care International is also the parent company of LBI LBI Long Beach Island (New Jersey Shore)
LBI Leo Baeck Institute
LBI Limited Background Investigation
LBI Legally Binding Instrument
LBI Leveraged Buy In
LBI Long Baseline Interferometer
LBI Last Block Indicator
 Brokerage, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, distributor of the Eye Care International Vision Plan and the Transamerica Worksite program, and now, the N-CAM(R) product line as well.

For more information about Eye Care International, visit www.ecivisionplan.com. For more information about N-CAM(R), visit www.N-CAM.com.

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such forward-looking statements involve risk and uncertainties, including, but not limited to, the successful implementation of the Company's programs, availability of financing and results of financing efforts. Further information regarding these and other risks is described from time to time in filings with the SEC.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 20, 2004
Words:468
Previous Article:American Healthways Reports First-Quarter Earnings of $0.22 Per Diluted Share Compared with $0.12 for First-Quarter Fiscal 2004.
Next Article:Network Appliance Maintains Lead in Secure Content and Application Delivery Market.



Related Articles
Molecular clue to schizophrenia.
HOSPITAL BUILDING ONLINE CONSTRUCTION CAN BE SEEN VIA WEB CAM.
Blindness: a sequela of sinonasal small cell neuroendocrine carcinoma.
MYSTERY OIL SOILED COASTAL BIRDS DYING.
Use of complementary and alternative medicine by parents of children with HIV infection and asthma and well children.
Monoclonal antibodies to the optic tectum and cerebellum of the bullfrog, Rana catesbeiana.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles